Deciphering the role of exosomal derived regulatory noncoding RNAs as potential biomarkers for diabetic retinopathy: a systematic review
2024

Exosomal Noncoding RNAs as Biomarkers for Diabetic Retinopathy

Sample size: 13 publication Evidence: low

Author Information

Author(s): Nandalal Santosh, Venkatesan Harshitha, Haridoss Madhumitha, Ramachandran Krithika

Primary Institution: SRM Institute of Science and Technology

Hypothesis

This study aims to summarize evidence on the role of altered exosomal regulatory noncoding RNAs in diabetic retinopathy based on human studies.

Conclusion

The review highlights the critical roles of exosomal noncoding RNAs in the pathogenesis of diabetic retinopathy, emphasizing their potential as therapeutic targets.

Supporting Evidence

  • About one-third of individuals with diabetes develop diabetic retinopathy.
  • Current treatments only show recovery in 50% of cases.
  • Novel early detection methods and new biomarkers are crucial for managing diabetic retinopathy.

Takeaway

This study looks at tiny molecules in our body that might help doctors find out if someone has a serious eye problem caused by diabetes.

Methodology

The study conducted a systematic review of observational studies on exosomal noncoding RNAs in diabetic retinopathy, following PRISMA guidelines.

Potential Biases

High risk of bias due to poor study design and lack of sample size justification.

Limitations

The studies included showed high variability in sample types and methodologies, and no common differentially expressed ncRNAs were identified.

Participant Demographics

The studies included participants with Type 2 Diabetes Mellitus and diabetic retinopathy.

Digital Object Identifier (DOI)

10.1186/s40942-024-00615-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication